Renovated cath lab in Michigan begins using bioresorbable heart stents

McLaren Oakland Hospital in Pontiac, Michigan, has renovated its cardiac catheter lab and has begun using Abbot Vascular’s Absorb naturally-dissolving heart stents, reports the Oakland Press.

The expansion will allow physicians to diagnose and treat peripheral vascular disease, and other heart diseases that could be treated with the stent. The stent is made of naturally-dissolving material and disappears after three years.

“The approval and launch of this device represents a significant advancement in our ability to treat chronic heart disease,” said Timothy Logan, MD, an interventional cardiologist with the McLaren Cardiovascular Institute. “Dissolved entirely after three years, patients and physicians alike don’t have to commit themselves to a permanent implant, leading to reduced anxiety while also maintaining the standard of care.”

To read more about the cath lab’s expansion, follow the link below:

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.